Cargando…

Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease

Nuclear factor erythroid 2-like 2 (NRF2) encodes a transcription factor regulating mechanisms of cellular protection and is activated by oxidative stress. NRF2 has therefore been hypothesized to confer protection against Parkinson's disease and so far an NRF2 haplotype has been reported to decr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ran, Caroline, Wirdefeldt, Karin, Brodin, Lovisa, Ramezani, Mehrafarin, Westerlund, Marie, Xiang, Fengqing, Anvret, Anna, Willows, Thomas, Sydow, Olof, Johansson, Anders, Galter, Dagmar, Svenningsson, Per, Belin, Andrea Carmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433415/ https://www.ncbi.nlm.nih.gov/pubmed/28540099 http://dx.doi.org/10.1155/2017/4020198

Ejemplares similares

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden
por: Ran, Caroline, et al.
Publicado: (2016)

Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson’s Disease
por: Anvret, Anna, et al.
Publicado: (2012)

Possible Involvement of a Mitochondrial Translation Initiation Factor 3 Variant Causing Decreased mRNA Levels in Parkinson's Disease
por: Anvret, Anna, et al.
Publicado: (2010)

DJ-1 Mutations are Rare in a Swedish Parkinson Cohort
por: Anvret, Anna, et al.
Publicado: (2011)

No Association Between rs7077361 in ITGA8 and Parkinson’s Disease in Sweden
por: Ran, Caroline, et al.
Publicado: (2016)

Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017)

Vagotomy and Parkinson disease: A Swedish register–based matched-cohort study
por: Liu, Bojing, et al.
Publicado: (2017)

S100B polymorphisms are associated with age of onset of Parkinson’s disease
por: Fardell, Camilla, et al.
Publicado: (2018)

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
por: Sundgren, Mathias, et al.
Publicado: (2021)

Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson’s and Alzheimer’s disease
por: Gellhaar, Sandra, et al.
Publicado: (2017)

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
por: Svenningsson, Per, et al.
Publicado: (2018)

Socioeconomic status in relation to Parkinson's disease risk and mortality: A population-based prospective study
por: Yang, Fei, et al.
Publicado: (2016)

Neuroticism, Smoking, and the Risk of Parkinson’s Disease
por: Sieurin, Johanna, et al.
Publicado: (2021)

Appendectomy, Tonsillectomy and Parkinson's Disease Risk: A Swedish Register-Based Study
por: Liu, Bojing, et al.
Publicado: (2020)

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Pupil light reflex dynamics in Parkinson’s disease
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

A linkage study of candidate loci in familial Parkinson's Disease
por: Wirdefeldt, Karin, et al.
Publicado: (2003)

Early-Life Factors and Risk of Parkinson’s Disease: A Register-Based Cohort Study
por: Liu, Bojing, et al.
Publicado: (2016)

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
por: Bergquist, Filip, et al.
Publicado: (2022)

Dietary antioxidants and risk of Parkinson's disease in two population‐based cohorts
por: Yang, Fei, et al.
Publicado: (2017)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

Antidepressant-like properties of sarizotan in experimental Parkinsonism
por: Zhang, Xiaoqun, et al.
Publicado: (2011)

Recent Updates on mRNA Vaccines
por: Sydow, Emily, et al.
Publicado: (2022)

Occupational stress and risk for Parkinson's disease: A nationwide cohort study
por: Sieurin, Johanna, et al.
Publicado: (2018)

Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson’s disease
por: Waldthaler, Josefine, et al.
Publicado: (2019)

msl2 mRNA is bound by free nuclear MSL complex in Drosophila melanogaster
por: Johansson, Anna-Mia, et al.
Publicado: (2011)

Feasibility Aspects of Exploring Exercise-Induced Neuroplasticity in Parkinson's Disease: A Pilot Randomized Controlled Trial
por: Johansson, Hanna, et al.
Publicado: (2020)

Construcciónes romanas
por: Subias Galter, Juan
Publicado: (1942)

Irritable bowel syndrome and Parkinson’s disease risk: register-based studies
por: Liu, Bojing, et al.
Publicado: (2021)

Genetic overlap between Parkinson’s disease and inflammatory bowel disease
por: Kang, Xiaoying, et al.
Publicado: (2023)

Occupational Complexity and Risk of Parkinson's Disease
por: Valdés, Elise G., et al.
Publicado: (2014)

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
por: Green, Holly F., et al.
Publicado: (2019)

Patterns of brain activity during a set-shifting task linked to mild behavioral impairment in Parkinson’s disease
por: Jin Yoon, Eun, et al.
Publicado: (2021)

Body mass index, sitting time, and risk of Parkinson disease
por: Roos, Elin, et al.
Publicado: (2018)

Heart rate, intelligence in adolescence, and Parkinson’s disease later in life
por: Longinetti, Elisa, et al.
Publicado: (2021)

Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
por: Brodin, Daniel, et al.
Publicado: (2023)

Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis
por: Fang, Fang, et al.
Publicado: (2011)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

Comparing ‘clinical hunch’ against clinical decision support systems (PERC rule, wells score, revised Geneva score and YEARS criteria) in the diagnosis of acute pulmonary embolism
por: Medson, Koshiar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qiagnv5poh0kpcr54km2knkdkd